We are live on ! Find out more
FCMI

Foresite Capital Management IV Portfolio holdings

AUM $237M
1-Year Est. Return 107.53%
This Fund
S&P 500
This Quarter Est. Return
-5.51%
1 Year Est. Return
+107.53%
3 Year Est. Return
+149.4%
5 Year Est. Return
+13.8%
10 Year Est. Return
–
AUM
$679M
AUM Growth
-$60.7M
Cap. Flow
-$15.3M
Cap. Flow %
-2.25%
Top 10 Hldgs %
99.26%
Holding
14
New
1
Increased
–
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
HLTH
Cue Health Inc. Common Stock
HLTH
+$15.8M

Top Sells

Rank Stock Value
1
RLAY icon
Relay Therapeutics
RLAY
+$20.4M
2
CYTK icon
Cytokinetics
CYTK
+$10.8M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KNTE
1
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$223M 32.78%
9,671,643
– –
LYEL icon
2
Lyell Immunopharma
LYEL
$317M
$197M 28.95%
664,109
– –
ACRS icon
3
Aclaris Therapeutics
ACRS
$726M
$61.2M 9.01%
3,399,034
– –
PHVS icon
4
Pharvaris
PHVS
$2.28B
$57.8M 8.52%
3,261,926
– –
QSI icon
5
Quantum-Si Incorporated
QSI
$155M
$37.2M 5.48%
4,463,619
– –
NRIX icon
6
Nurix Therapeutics
NRIX
$2.41B
$36.1M 5.32%
1,205,798
– –
KURA icon
7
Kura Oncology
KURA
$800M
$34.6M 5.1%
1,849,947
– –
HLTH
8
DELISTED
Cue Health Inc. Common Stock
HLTH
$11.9M 1.75%
+1,006,089
New +$15.8M
OLMA icon
9
Olema Pharmaceuticals
OLMA
$1B
$9.43M 1.39%
342,030
– –
CBAY
10
DELISTED
Cymabay Therapeutics
CBAY
$6.52M 0.96%
1,787,094
– –
TPST icon
11
Tempest Therapeutics
TPST
$13.7M
$2.75M 0.41%
14,632
– –
DBTX
12
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$2.29M 0.34%
297,711
– –
CYTK icon
13
Cytokinetics
CYTK
$10.5B
– –
-545,101
Closed -$10.8M
RLAY icon
14
Relay Therapeutics
RLAY
$4.1B
– –
-556,380
Closed -$20.4M

Similar funds

BCM
Birmingham Capital Management Birmingham, Alabama $237M AUM 32.7% 1-Year Est. Return
AG
ASO Group Road Town $237M AUM
FL
FreeGulliver LLC New Orleans, Louisiana $237M AUM 21.92% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
MFA
Millington Financial Advisors Naperville, Illinois $237M AUM 22.22% 1-Year Est. Return
TCM
Tekne Capital Management New York $237M AUM 62.98% 1-Year Est. Return
WW
Windle Wealth Oklahoma City, Oklahoma $237M AUM 22.79% 1-Year Est. Return
CB
CNB Bank Clearfield, Pennsylvania $238M AUM 26.55% 1-Year Est. Return

Foresite Capital Management IV's Q3 2021 Portfolio in Review

As of Q3 2021, Foresite Capital Management IV held 14 positions worth $679M, down 8.2% from $740M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Foresite Capital Management IV's Q3 2021 filing shows 1 new and 2 closed positions. Its largest new stake was Cue Health Inc. Common Stock: 1,006,089 shares worth $11.9M. The largest sale was Relay Therapeutics, an estimated $20.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Foresite Capital Management IV's largest Q3 2021 buy was Cue Health Inc. Common Stock: 1,006,089 shares worth $11.9M.
  • Foresite Capital Management IV fully exited Relay Therapeutics in Q3 2021, selling an estimated $20.4M.
  • Foresite Capital Management IV's ten largest holdings make up 99% of its $679M portfolio in Q3 2021.
  • Foresite Capital Management IV opened 1 new position and closed 2 in Q3 2021.
  • Foresite Capital Management IV's portfolio value fell 8.2% quarter-over-quarter to $679M.

Based on Foresite Capital Management IV's 13F filing for Q3 2021, filed 12 Nov 2021.